Adam S. Grossman
2019
In 2019, Adam S. Grossman earned a total compensation of $1.7M as Director, President and Chief Executive Officer at ADMA Biologics, a 10% increase compared to previous year.
Compensation breakdown
| Bonus | $368,500 |
|---|---|
| Option Awards | $760,858 |
| Salary | $536,000 |
| Other | $36,664 |
| Total | $1,702,022 |
Grossman received $760.9K in option awards, accounting for 45% of the total pay in 2019.
Grossman also received $368.5K in bonus, $536K in salary and $36.7K in other compensation.
Rankings
In 2019, Adam S. Grossman's compensation ranked 6,704th out of 13,971 executives tracked by ExecPay. In other words, Grossman earned more than 52.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,704 out of 13,971 | 52nd |
Division Manufacturing | 2,555 out of 5,692 | 55th |
Major group Chemicals And Allied Products | 934 out of 2,189 | 57th |
Industry group Drugs | 789 out of 1,875 | 58th |
Industry Biological Products, Except Diagnostic Substances | 191 out of 389 | 51st |
Source: SEC filing on April 29, 2020.
Grossman's colleagues
We found two more compensation records of executives who worked with Adam S. Grossman at ADMA Biologics in 2019.
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019